Chemistry / Nuclear & Radiochemistry Decay Kinetics, Fission, Fusion & Radiometrics 100% Free Open Access
Chapter 10 β€’ Theory & Derivations

Unit 10: Radiation Dosimetry, Radiobiology & Radioprotection (ALARA)

Comprehensive metrological, biological, and operational framework for radiation safety: fundamental physical dosimetric quantities (Exposure, Absorbed Dose, Equivalent Dose, Effective Dose); the Bragg-Gray cavity principle; molecular radiobiology and water radiolysis; DNA double-strand break repair and the Linear-Quadratic cell survival model; deterministic tissue reactions versus stochastic carcinogenesis; the ALARA philosophy; and shielding attenuation optimization.

Β§10.1 Physical Dosimetric Quantities: Exposure, Absorbed Dose & the Bragg-Gray Cavity Principle

Radiation dosimetry is the quantitative science of measuring and calculating the energy deposited by ionizing radiation in matter and biological tissue.

1. Exposure ($X$)

The historical quantity defining the ionizing capacity of X-ray and gamma-ray photons in dry air under conditions of electronic equilibrium:

$$X = \frac{dQ}{dm}$$

where $dQ$ is the total electrical charge of ions of one sign produced in air when all secondary electrons liberated by photons in dry air of mass $dm$ are completely stopped.

  • SI Unit: Coulomb per kilogram ($\text{C/kg}$).
  • Traditional Unit: The Roentgen (R):
$$1\text{ R} \equiv 2.58 \times 10^{-4}\text{ C/kg of dry air (exactly)}$$

Because producing one ion pair in dry air requires $W_{\text{air}} \approx 33.97\text{ eV} = 33.97\text{ J/C}$, an exposure of $1\text{ R}$ corresponds to an energy absorption of:

$$D_{\text{air}}(1\text{ R}) = (2.58 \times 10^{-4}\text{ C/kg})(33.97\text{ J/C}) \approx 8.76 \times 10^{-3}\text{ J/kg} = 0.876\text{ rad} = 8.76\text{ mGy}$$

2. Absorbed Dose ($D$)

The fundamental physical quantity applicable to all types of ionizing radiation (photons, electrons, neutrons, heavy ions) in any absorbing material:

$$D = \frac{d\bar{\epsilon}}{dm}$$

where $d\bar{\epsilon}$ is the mean energy imparted by ionizing radiation to matter of mass $dm$.

  • SI Unit: The Gray (Gy):
$$1\text{ Gy} \equiv 1\text{ Joule per kilogram (J/kg)}$$
  • Traditional Unit: The rad (radiation absorbed dose):
$$1\text{ rad} \equiv 100\text{ erg/g} = 0.01\text{ J/kg} = 0.01\text{ Gy} \quad (1\text{ Gy} = 100\text{ rad})$$

3. Kerma ($K$, Kinetic Energy Released per unit MAss)

For uncharged radiation (photons and neutrons), Kerma quantifies the kinetic energy transferred to initial secondary charged particles:

$$K = \frac{dE_{\text{tr}}}{dm}$$

Under conditions of Charged Particle Equilibrium (CPE) where radiative losses are negligible:

$$D = K_{\text{col}} \approx K$$

4. The Bragg-Gray Cavity Principle

To measure absorbed dose inside a solid medium (e.g., patient tissue or water phantom), an ionization gas cavity is introduced. According to the Bragg-Gray theorem, if the cavity is sufficiently small that it does not perturb the fluence of secondary electrons crossing it:

$$D_{\text{med}} = D_{\text{gas}} \cdot \bar{s}_{\text{med, gas}} = \left(\frac{Q}{m_{\text{gas}}} \frac{W_{\text{gas}}}{e}\right) \bar{s}_{\text{med, gas}}$$

where $\bar{s}_{\text{med, gas}} = (S/\rho)_{\text{med}} / (S/\rho)_{\text{gas}}$ is the ratio of mass stopping powers of the medium to the cavity gas. This allows ionization current measured in a gas chamber to be converted directly into absorbed dose in patient tissue.

Β§10.2 Radiation Weighting Factors, Equivalent Dose & Tissue-Weighted Effective Dose

Absorbed dose ($D$, in Grays) quantifies physical energy deposition, but does not describe biological damage. A dose of $1\text{ Gy}$ delivered by dense alpha particles produces vastly greater biological lethality than $1\text{ Gy}$ delivered by dispersed gamma photons.

1. Equivalent Dose ($H_T$)

To quantify biological risk across different radiation modalities, the International Commission on Radiological Protection (ICRP) defines the Equivalent Dose $H_T$ in an organ or tissue $T$:

$$H_T \equiv \sum_R w_R \cdot D_{T, R}$$

where $D_{T, R}$ is the absorbed dose delivered by radiation type $R$, and $w_R$ is the dimensionless Radiation Weighting Factor:

| Radiation Type and Energy Spectrum | Radiation Weighting Factor ($w_R$) | Biological Justification | | :--- | :--- | :--- | | Photons (X-rays, $\gamma$-rays, all energies) | $1$ | Reference low-LET standard | | Electrons, positrons, muons (all energies) | $1$ | Sparsely ionizing track structure | | Protons and charged pions | $2$ | Moderate linear energy transfer | | Alpha particles, fission fragments, heavy ions | $20$ | High LET ($\sim 100\text{ keV}/\mu\text{m}$), dense double-strand breaks | | Neutrons: Thermal ($< 1\text{ keV}$) | $2.5$ | Indirect proton recoil / capture | | Neutrons: Epithermal & Fast ($0.1 - 2\text{ MeV}$) | $20$ (Peak at $1\text{ MeV}$) | Maximum recoil proton stopping power | | Neutrons: High Energy ($> 20\text{ MeV}$) | $5 - 10$ | Nuclear spallation reactions |

  • SI Unit: The Sievert (Sv):
$$1\text{ Sv} \equiv 1\text{ J/kg} \quad (\text{Subunits: } \text{mSv} = 10^{-3}\text{ Sv}, \, \mu\text{Sv} = 10^{-6}\text{ Sv})$$
  • Traditional Unit: The rem (Roentgen equivalent man):
$$1\text{ rem} \equiv 0.01\text{ Sv} = 10\text{ mSv} \quad (1\text{ Sv} = 100\text{ rem})$$

2. Effective Dose ($E$)

Different human organs and tissues exhibit vastly different sensitivities to radiation-induced cancer and genetic damage. The Effective Dose $E$ quantifies the overall stochastic health risk to the entire individual:

$$E \equiv \sum_T w_T \cdot H_T = \sum_T w_T \left( \sum_R w_R \cdot D_{T, R} \right)$$

where $w_T$ is the Tissue Weighting Factor representing the relative contribution of organ $T$ to total stochastic risk:

``` TISSUE / ORGAN (ICRP Publication 103) w_T FRACTION ───────────────────────────────────────────────────────────────────────────── Red Bone Marrow, Colon, Lung, Stomach, Breast, Remainder 0.12 ea 72.0% Gonads (Testes / Ovaries - Genetic Hereditary Detriment) 0.08 8.0% Urinary Bladder, Esophagus, Liver, Thyroid 0.04 ea 16.0% Bone Surface, Brain, Salivary Glands, Skin 0.01 ea 4.0% ───────────────────────────────────────────────────────────────────────────── TOTAL SUM (Whole Body Normalized): 1.00 100.0% ```

Effective dose allows partial-body medical exposures (e.g., a chest CT scan delivering $7\text{ mSv}$) to be compared directly with whole-body natural background radiation ($\approx 2.4 - 3.0\text{ mSv/year}$).

Β§10.3 Molecular Radiobiology: Radiolysis of Water, Free Radical Cascades & DNA Double-Strand Breaks

Living biological cells consist of approximately $70 - 85\%$ liquid water. When ionizing radiation traverses biological tissue, energy deposition damages critical cellular targets via two distinct pathways:

``` IONIZING RADIATION β”‚ β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β” β–Ό (~35%) β–Ό (~65%) DIRECT ACTION INDIRECT ACTION Direct ionization of Radiolysis of cellular water nuclear DNA macromolecule (Free radical generation: β€’OH) β”‚ β”‚ β”‚ β–Ό └───────────────────────► DNA LESIONS (Single & Double Strand Breaks) ```

The Radiolysis of Water

Within $10^{-16}\text{ to }10^{-12}\text{ seconds}$ of radiation passage, water molecules undergo ionization and electronic excitation:

$$\text{H}_2\text{O} \rightsquigarrow \text{H}_2\text{O}^{+\bullet} + e^-$$
$$\text{H}_2\text{O} \rightsquigarrow \text{H}_2\text{O}^*$$

1. Hydrated Electron Formation:

The ejected fast electron thermalizes and becomes trapped in the dielectric dipole cage of surrounding water molecules within $\sim 1\text{ picosecond}$:

$$e^- + n \text{H}_2\text{O} \longrightarrow e_{\text{aq}}^- \quad (\text{Hydrated Electron: powerful reducing agent, } E^\circ = -2.87\text{ V})$$

2. Hydroxyl Radical Generation:

The radical cation $\text{H}_2\text{O}^{+\bullet}$ reacts with neighboring water via ultrafast proton transfer:

$$\text{H}_2\text{O}^{+\bullet} + \text{H}_2\text{O} \longrightarrow \text{H}_3\text{O}^+ + \cdot\text{OH}$$

The hydroxyl radical ($\cdot\text{OH}$) is an extraordinarily reactive, neutral oxidizer ($E^\circ = +2.80\text{ V}$) responsible for over $65\%$ of all indirect DNA damage in biological cells.

3. Hydrogen Radicals and Radiolytic Products:

$$\text{H}_2\text{O}^* \longrightarrow \text{H}\cdot + \cdot\text{OH}$$
$$\cdot\text{OH} + \cdot\text{OH} \longrightarrow \text{H}_2\text{O}_2 \quad (\text{Hydrogen Peroxide})$$
$$\text{H}\cdot + \text{O}_2 \longrightarrow \text{HO}_2\cdot \rightleftharpoons \text{H}^+ + \text{O}_2^{-\bullet} \quad (\text{Superoxide Radical})$$

DNA Lesion Spectrum and Double-Strand Breaks (DSBs)

A typical mammalian cell nucleus ($V \approx 500\,\mu\text{m}^3$) contains $6 \times 10^9$ base pairs of double-helical genomic DNA. A uniform absorbed dose of $1\text{ Gy}$ of low-LET X-rays produces:

  • $\sim 100,000$ water ionization events.
  • $\sim 1,000 - 2,000$ base damages (oxidized guanines, e.g., 8-oxo-dG).
  • $\sim 1,000$ Single-Strand Breaks (SSBs).
  • $\sim 40$ Double-Strand Breaks (DSBs).

While SSBs are repaired with high fidelity by DNA ligases using the intact complementary strand as a template, Double-Strand Breaks (where both opposing phosphodiester backbones are severed within $10 - 20$ base pairs) represent the critical lethal lesion. Misrepair of DSBs via Non-Homologous End Joining (NHEJ) causes dicentric chromosomal aberrations, ring chromosomes, translocations, and apoptotic cell death.

Β§10.4 Linear Energy Transfer (LET), Relative Biological Effectiveness (RBE) & the Linear-Quadratic Model

The biological consequence of a given absorbed dose depends fundamentally on the spatial track structure of ionization events, characterized by Linear Energy Transfer (LET).

Linear Energy Transfer (LET)

LET quantifies the average energy transferred locally to the absorbing medium per unit path length ($\text{keV}/\mu\text{m}$):

$$L_\Delta = \left(\frac{dE}{dx}\right)_\Delta$$
  • Low-LET Radiation ($< 10\text{ keV}/\mu\text{m}$): Cobalt-60 gamma rays ($0.2\text{ keV}/\mu\text{m}$), $250\text{ kVp}$ X-rays ($2\text{ keV}/\mu\text{m}$), fast electrons. Ionization events are spaced hundreds of nanometers apart, producing isolated, easily repairable lesions.
  • High-LET Radiation ($> 20\text{ keV}/\mu\text{m}$): Alpha particles ($100\text{ keV}/\mu\text{m}$), heavy recoil ions ($>1000\text{ keV}/\mu\text{m}$). Ionization events form dense, continuous columns that deposit dozens of ion pairs across a single $2\text{ nm}$ DNA diameter, producing complex, unrepairable clustered damage.

Relative Biological Effectiveness (RBE)

RBE is defined as the ratio of absorbed dose of reference $250\text{ kVp}$ X-rays ($D_{\text{ref}}$) to the dose of test radiation ($D_{\text{test}}$) required to achieve an identical biological endpoint (e.g., $10\%$ cell survival):

$$\text{RBE} \equiv \left. \frac{D_{\text{ref}}}{D_{\text{test}}} \right|_{\text{equal effect}}$$

``` RBE (Relative Biological Effectiveness) β–² β”‚ PEAK RBE (~ 100 keV/ΞΌm) β”‚ /\ β”‚ / \ β”‚ / \ Overkill Effect β”‚ Low-LET / \ (Wasted Dose) β”‚ ───────┐ / \_____ β”‚ └─────────/ └───────────────────┴──────────┴────► LET (keV / ΞΌm) 0.1 10 100 1000 ```

  • As LET increases from $1$ to $100\text{ keV}/\mu\text{m}$, RBE climbs steeply to a maximum peak at $\approx 100\text{ keV}/\mu\text{m}$. At this optimal density, the average spacing between ionizing events ($\sim 2\text{ nm}$) corresponds precisely to the diameter of the DNA double helix!
  • Beyond $100\text{ keV}/\mu\text{m}$, RBE drops due to the overkill effect: more energy is deposited in the cell nucleus than is required for cell sterilization, wasting excess dose.

The Linear-Quadratic (LQ) Cell Survival Model

Cell survival curves plot surviving fraction $S(D)$ versus absorbed dose $D$. The universally accepted biophysical model is the Linear-Quadratic Model:

$$S(D) = \exp\left( -\alpha D - \beta D^2 \right)$$

where:

  • $\alpha$ is the linear coefficient ($\text{Gy}^{-1}$), representing lethal single-hit "unrepairable" track damage (intra-track DSB).
  • $\beta$ is the quadratic coefficient ($\text{Gy}^{-2}$), representing two independent radiation tracks interacting to produce a lethal lesion (inter-track repairable damage).
  • The ratio $\alpha/\beta$ (units of $\text{Gy}$) defines the dose at which the linear and quadratic cell-killing contributions are equal ($\alpha D = \beta D^2 \implies D = \alpha/\beta$).
  • Early-responding tissues / Tumors: High $\alpha/\beta \approx 10\text{ Gy}$ (steep linear survival, minimal fractionation sparing).
  • Late-responding normal tissues: Low $\alpha/\beta \approx 2 - 3\text{ Gy}$ (broad curve shoulder, massive sparing with fractionated radiation therapy).

Β§10.5 Deterministic Tissue Reactions Versus Stochastic Carcinogenesis & the LNT Paradigm

The biological consequences of ionizing radiation are categorized into two fundamentally distinct classes:

1. Deterministic Effects (Tissue Reactions)

Arise from radiation-induced killing of large populations of functional tissue cells:

  • Threshold Dose: A clear, finite dose threshold $D_{\text{th}}$ exists below which no clinical effect is observable. Above the threshold, the severity of the injury increases monotonically with dose.
  • Pathology: Acute cell depletion, vascular damage, and fibrotic tissue death.
  • Representative Thresholds:
  • Temporary Sterility (Testes): $0.15\text{ Gy}$ ($150\text{ mGy}$).
  • Depression of Hematopoiesis (Bone Marrow): $0.50\text{ Gy}$.
  • Skin Erythema (Reddening): $3 - 5\text{ Gy}$; Dry Desquamation: $10\text{ Gy}$; Necrosis: $>15\text{ Gy}$.
  • Radiation Cataractogenesis (Lens of Eye): $0.5\text{ Gy}$ (ICRP 118).
  • Acute Radiation Syndrome (ARS, Whole Body):
  • Hematopoietic Syndrome: $1 - 6\text{ Gy}$ ($50\%$ lethal dose without medical care: $\text{LD}_{50/60} \approx 3.5 - 4.0\text{ Gy}$).
  • Gastrointestinal (GI) Syndrome: $6 - 20\text{ Gy}$ (destruction of crypt stem cells; lethal within $1 - 2\text{ weeks}$).
  • Cerebrovascular Syndrome: $>20 - 50\text{ Gy}$ (cardiovascular collapse and brain edema; lethal within $24 - 48\text{ hours}$).

2. Stochastic Effects (Cancer and Heritable Mutations)

Arise from non-lethal, mutagenic alteration of a single somatic stem cell that survives with an oncogenic mutation:

  • No Threshold: Governed by probability rather than severity. Even an infinitesimal dose has a non-zero probability of inducing a malignant transformation.
  • Severity is Independent of Dose: A cancer induced by a $10\text{ mSv}$ dose is clinically identical to one induced by a $1000\text{ mSv}$ dose; only the probability of occurrence scales with dose.
  • Latent Period: Solid cancers manifest after long latency periods ($10 - 40\text{ years}$); leukemias manifest after $2 - 10\text{ years}$.

``` STOCHASTIC EFFECTS DETERMINISTIC EFFECTS Probability of Cancer Severity of Tissue Injury β–² β–² β”‚ / β”‚ / β”‚ / β”‚ / β”‚ / β”‚ / β”‚ LNT Model / β”‚ / β”‚ / β”‚ / β”‚ / β”‚ / β”‚ / β”‚ / β”‚_________/ β”‚______________/_ └─────────┴────────────────► Dose D └──────────────┴─────► Dose D 0 0 D_th (Threshold) ```

The Linear No-Threshold (LNT) Model

For radiation protection regulation, the ICRP, NCRP, and IAEA adopt the Linear No-Threshold (LNT) hypothesis: The excess lifetime risk of fatal stochastic cancer is assumed to be strictly proportional to effective dose, extrapolating linearly from high-dose epidemiological data (Hiroshima and Nagasaki atomic bomb survivors, Life Span Study LSS) down to zero dose.

  • ICRP Detriment Coefficient:
$$\text{Nominal Risk Coefficient} \approx 5.5\% \text{ per Sievert} = 5.5 \times 10^{-2}\text{ Sv}^{-1} \quad (0.0055\%\text{ per mSv})$$

For an occupational worker receiving an annual effective dose of $20\text{ mSv}$, the lifetime excess cancer mortality risk is:

$$\text{Risk} = (0.020\text{ Sv}) \times 0.055\text{ Sv}^{-1} = 0.0011 \quad (0.11\% \text{ or } 1 \text{ in } 900)$$

Β§10.6 Practical Radioprotection Metrology: Time, Distance (Inverse Square) & Shielding Optimization

The operational foundation of external radiation protection rests on the three classical pillars: Time, Distance, and Shielding.

1. Time Optimization

The total accumulated absorbed dose $D$ is directly proportional to exposure duration $t$:

$$D = \dot{D} \cdot t$$

Minimizing residence time in a radiation field reduces dose proportionally. Practicing complex manipulation protocols using non-radioactive mockups ("dry runs") before handling high-activity sources minimizes hands-on handling time.

2. Distance Optimization (The Inverse Square Law)

For an isotropic point source emitting radiation, photon flux spreads over the spherical surface area $4\pi d^2$. The radiation intensity and dose rate $\dot{D}$ decrease inversely with the square of the distance $d$:

$$\dot{D}(d) = \dot{D}_0 \left(\frac{d_0}{d}\right)^2 \implies \frac{\dot{D}_1}{\dot{D}_2} = \frac{d_2^2}{d_1^2}$$

Doubling distance ($2d$) reduces dose rate by a factor of $4$ ($25\%$); increasing distance tenfold ($10d$) reduces dose rate by a factor of $100$ ($1\%$)!

  • Practical Application: Never touch unshielded gamma or beta sources with bare hands! Using a $30\text{ cm}$ remote handling tongs instead of direct fingertip contact ($1\text{ cm}$) reduces the dose rate by a factor of:
$$(30 / 1)^2 = 900 \text{ times}$$

Gamma Constant ($\Gamma$) for Point Sources

The exposure rate $\dot{X}$ at distance $d$ from a point gamma emitter of activity $A$ is parameterized by the Specific Gamma-Ray Constant $\Gamma$:

$$\dot{X} = \frac{\Gamma \cdot A}{d^2}$$

For air kerma rate constant $\Gamma_\delta$ ($\mu\text{Gy}\cdot\text{m}^2/\text{GBq}\cdot\text{h}$):

  • $^{60}\text{Co}$: $\Gamma \approx 308\,\mu\text{Gy}\cdot\text{m}^2 / (\text{GBq}\cdot\text{h}) = 1.32\text{ R}\cdot\text{m}^2 / (\text{Ci}\cdot\text{h})$
  • $^{137}\text{Cs}$: $\Gamma \approx 78\,\mu\text{Gy}\cdot\text{m}^2 / (\text{GBq}\cdot\text{h}) = 0.33\text{ R}\cdot\text{m}^2 / (\text{Ci}\cdot\text{h})$
  • $^{192}\text{Ir}$: $\Gamma \approx 115\,\mu\text{Gy}\cdot\text{m}^2 / (\text{GBq}\cdot\text{h}) = 0.48\text{ R}\cdot\text{m}^2 / (\text{Ci}\cdot\text{h})$
  • $^{99m}\text{Tc}$: $\Gamma \approx 17\,\mu\text{Gy}\cdot\text{m}^2 / (\text{GBq}\cdot\text{h}) = 0.076\text{ R}\cdot\text{m}^2 / (\text{Ci}\cdot\text{h})$

3. Shielding Optimization

When distance and time limits are reached, physical barriers attenuate radiation exponentially:

$$\dot{D}(x) = \dot{D}_0 \cdot B(x, E) \cdot e^{-\mu x} = \dot{D}_0 \cdot B(x, E) \cdot 2^{-x / \text{HVL}} = \dot{D}_0 \cdot B(x, E) \cdot 10^{-x / \text{TVL}}$$

Combining distance and shielding:

$$\dot{D}(d, x) = \frac{\Gamma \cdot A}{d^2} \cdot B \cdot e^{-\mu x}$$

Β§10.7 The ALARA Philosophy, International Regulatory Frameworks & Internal Biokinetic Dosimetry

Under the guidance of the International Commission on Radiological Protection (ICRP Publication 103), global radiation safety is governed by three fundamental ethical and operational principles:

1. Justification: No practice involving exposure to radiation should be adopted unless it produces a net positive societal or individual benefit sufficient to offset the radiation detriment.

2. Optimization (The ALARA Principle): All exposures must be maintained As Low As Reasonably Achievable (ALARA), economic and societal factors being taken into account.

3. Dose Limitation: Total individual doses must not exceed statutory regulatory limits to prevent deterministic effects and limit stochastic risk.

Statutory Dose Limits (ICRP & IAEA Basic Safety Standards)

| Exposed Population Group | Effective Dose Limit (Whole Body) | Equivalent Dose: Lens of Eye | Equivalent Dose: Skin & Extremities | | :--- | :--- | :--- | :--- | | Occupational Radiation Workers | $20\text{ mSv/year}$ (averaged over 5 yr; max $50\text{ mSv}$ in any single yr) | $20\text{ mSv/year}$ (reduced from $150$) | $500\text{ mSv/year}$ ($50\text{ rem}$) | | Pregnant Radiation Workers | $1\text{ mSv}$ to fetus post-declaration | β€” | β€” | | General Public | $1.0\text{ mSv/year}$ ($0.1\text{ rem/year}$) | $15\text{ mSv/year}$ | $50\text{ mSv/year}$ |

Notice that medical patients undergoing diagnostic or therapeutic procedures are strictly exempt from dose limits; their exposure is governed exclusively by clinical justification and protocol optimization.

Internal Dosimetry & Biokinetic Compartmental Models

When radionuclides are inhaled, ingested, or absorbed into wounds, they distribute throughout biological compartments, delivering continuous internal radiation until eliminated by physical radioactive decay ($\lambda_p$) and biological clearance ($\lambda_b$). The effective elimination constant $\lambda_{\text{eff}}$ is:

$$\lambda_{\text{eff}} = \lambda_p + \lambda_b \implies \frac{1}{T_{\text{eff}}} = \frac{1}{T_p} + \frac{1}{T_b} \implies T_{\text{eff}} = \frac{T_p \cdot T_b}{T_p + T_b}$$

The effective half-life $T_{\text{eff}}$ is always strictly shorter than both the physical half-life $T_p$ and biological clearance half-life $T_b$.

  • Example: Cesium-137 ($^{137}\text{Cs}$): Physical $T_p = 30.17\text{ years}$, but biological clearance half-life in human tissue is $T_b \approx 70 - 100\text{ days}$. The internal effective half-life is $T_{\text{eff}} \approx 70 - 100\text{ days}$, preventing multi-decade internal retention.
  • Example: Strontium-90 ($^{90}\text{Sr}$): Bone-seeker incorporated into hydroxyapatite mineral matrix ($T_b \approx 50\text{ years}$), giving an effective half-life $T_{\text{eff}} \approx 18\text{ years}$ and delivering high cumulative bone marrow dose.

The cumulative internal dose delivered over 50 years ($70\text{ years}$ for children) is quantified as the Committed Effective Dose $E(50)$:

$$E(50) = A_{\text{intake}} \cdot e(50)$$

where $e(50)$ is the radionuclide-specific dose coefficient ($\text{Sv/Bq}$).

Β§10.8 Operational Health Physics: Internal Bioassay Mathematical Modeling & ALARA Engineering

Operational radiation safety transforms fundamental physical principles into engineering practices designed to keep occupational and public doses As Low As Reasonably Achievable (ALARA).

1. ICRP Human Respiratory Tract Model (HRTM, ICRP Publication 66 & 130)

Inhaled radioactive aerosols are deposited in respiratory compartments according to aerodynamic diameter ($AMAD$, Activity Median Aerodynamic Diameter, typically $1 - 5\,\mu\text{m}$):

  • Extrathoracic airways ($ET_1, ET_2$): Nose, pharynx, larynx.
  • Bronchial ($BB$) and bronchiolar ($bb$) tree: Ciliated mucociliary escalator transports particles upward to the esophagus within hours.
  • Alveolar-interstitial region ($AI$): Gas-exchange region lacking cilia; clearance is rate-limited by chemical solubility in alveolar macrophages.

Particles are classified by their chemical absorption rate into blood:

  • Type F (Fast): $100\%$ absorbed into systemic blood within minutes to hours (e.g., soluble nitrates, fluorides, pertechnetates).
  • Type M (Moderate): Half-times of days to weeks (e.g., oxides of uranium, carbonates, cobalt).
  • Type S (Slow): Highly insoluble refractory particulates (e.g., high-fired $\text{UO}_2, \text{PuO}_2$) retained in lung tissue and pulmonary lymph nodes for decades ($T_{\text{clearance}} > 7,000\text{ days}$).

2. In Vivo and In Vitro Bioassay Monitoring

To monitor occupational internal contamination:

  • In Vivo Whole-Body Counting (WBC): The worker sits in a heavily shielded low-background room (pre-WWII steel plate shielding) surrounded by large HPGe or $\text{NaI(Tl)}$ detectors to quantify high-energy gamma emitters ($^{60}\text{Co}, ^{137}\text{Cs}$). Specialized low-energy Germanium (LEGe) lung counters detect the faint $59.5\text{ keV}$ photons of $^{241}\text{Am}$ to assay insoluble plutonium contamination.
  • In Vitro Bioassay: Radiochemical separation and alpha spectrometry of 24-hour urine and fecal samples to detect sub-picocurie levels of alpha-emitting actinides ($^{239}\text{Pu}, ^{238}\text{U}, ^{232}\text{Th}$).

3. ALARA Engineering Controls

In nuclear engineering facility design:

1. Zoned Ventilation: Air flows strictly from zones of lowest contamination potential to zones of highest contamination potential (Zone 1: Offices $\to$ Zone 2: Hallways $\to$ Zone 3: Radiation Laboratories $\to$ Zone 4: Hot Cells). Hot cells operate under permanent negative gauge pressure ($-250\text{ Pa}$) to prevent aerosol leakage.

2. HEPA Filtration: Exhaust air passes through redundant series of Nuclear-Grade High-Efficiency Particulate Air (HEPA) filters ($99.97\%$ capture efficiency for $0.3\,\mu\text{m}$ particles) and charcoal beds to trap radioiodine vapors.

ICRP International System of Radiological Protection: Dose Limits & Detriment Metrics

``` ICRP DOSE LIMIT ARCHITECTURE (ICRP 103) β”‚ β”Œβ”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”΄β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β”€β” β–Ό β–Ό OCCUPATIONAL WORKERS GENERAL PUBLIC β€’ Effective Dose: 20 mSv/yr β€’ Effective Dose: 1.0 mSv/yr (Averaged over 5 yr; max 50 mSv in any 1 yr) (Higher in special circumstances) β€’ Equivalent Dose Lens: 20 mSv/yr β€’ Equivalent Dose Lens: 15 mSv/yr β€’ Equivalent Dose Skin: 500 mSv/yr β€’ Equivalent Dose Skin: 50 mSv/yr β€’ Equivalent Dose Hands/Feet: 500 mSv/yr β€’ Pregnant Public: Unrestricted ```

Major Radiological Accidents and Lessons Learned

1. Chernobyl (1986, INES Level 7):

Prompt criticality power excursion driven by positive void coefficient ($+4.5\,\beta$) during low-power turbine test with control rods withdrawn, followed by xenon pit poisoning. Release of $1.8 \times 10^{18}\text{ Bq}$ of $^{131}\text{I}$ and $8.5 \times 10^{16}\text{ Bq}$ of $^{137}\text{Cs}$. Resulted in 28 acute radiation deaths and over 6,000 thyroid cancers among children who drank milk contaminated with $^{131}\text{I}$.

2. Fukushima Daiichi (2011, INES Level 7):

Loss of all off-site power and on-site emergency diesel generators following a $14\text{-meter}$ tsunami. Loss of decay heat cooling caused core meltdowns in Units 1, 2, and 3. Zircaloy-water reaction ($Zr + 2\text{H}_2\text{O} \to \text{ZrO}_2 + 2\text{H}_2$) produced explosive hydrogen gas, blowing off reactor building roofs. Prompt evacuation and food bans prevented any acute radiation sickness or fatal deterministic exposures.

3. GoiΓ’nia (1987, INES Level 5):

Scrap metal scavengers dismantled an abandoned teletherapy machine, breaching a sealed cesium-137 chloride source ($50.9\text{ TBq} \approx 1375\text{ Ci}$). Attracted by its glowing blue luminescence in the dark, individuals spread the soluble powder across family members and neighborhoods. 4 fatalities from acute bone marrow syndrome; over 112,000 individuals screened.

Easy Example 10.1: Whole-Body Effective Dose Calculation from Mixed Radiation Field

A nuclear research worker in an accelerator vault accidentally receives a non-uniform mixed radiation exposure:

  • Lung receives $15.0\text{ mGy}$ of fast neutrons ($w_R = 20$).
  • Red bone marrow receives $8.0\text{ mGy}$ of gamma photons ($w_R = 1$) and $2.0\text{ mGy}$ of fast neutrons ($w_R = 20$).
  • Thyroid receives $25.0\text{ mGy}$ of gamma photons ($w_R = 1$).

Using ICRP tissue weighting factors: $w_T(\text{lung}) = 0.12$, $w_T(\text{marrow}) = 0.12$, and $w_T(\text{thyroid}) = 0.04$:

  1. Calculate the Equivalent Dose $H_T$ to the lung, bone marrow, and thyroid in millisieverts ($\text{mSv}$).
  2. Compute the total Effective Dose $E$ in $\text{mSv}$.
  3. Compare the result with the annual occupational limit of $20\text{ mSv}$.

Step 1: Equivalent Dose $H_T = \sum w_R D_{T,R}$

1. Lung:

$$H_{\text{lung}} = w_R(\text{neutron}) \cdot D = 20 \times 15.0\text{ mGy} = 300.0\text{ mSv}$$

2. Red Bone Marrow:

$$H_{\text{marrow}} = (1 \times 8.0\text{ mGy}) + (20 \times 2.0\text{ mGy}) = 8.0 + 40.0 = 48.0\text{ mSv}$$

3. Thyroid:

$$H_{\text{thyroid}} = 1 \times 25.0\text{ mGy} = 25.0\text{ mSv}$$

Step 2: Total Effective Dose $E = \sum w_T H_T$

$$E = [w_T(\text{lung}) \cdot H_{\text{lung}}] + [w_T(\text{marrow}) \cdot H_{\text{marrow}}] + [w_T(\text{thyroid}) \cdot H_{\text{thyroid}}]$$
$$E = (0.12 \times 300.0\text{ mSv}) + (0.12 \times 48.0\text{ mSv}) + (0.04 \times 25.0\text{ mSv})$$
$$E = 36.0\text{ mSv} + 5.76\text{ mSv} + 1.00\text{ mSv} = 42.76\text{ mSv}$$

Step 3: Regulatory Compliance

The total effective dose is $42.8\text{ mSv}$, which exceeds the annual occupational limit of $20\text{ mSv}$ (though it is below the single-year cap of $50\text{ mSv}$). A formal radiological investigation and dose tracking over 5 years are required.

Intermediate Example 10.2: Industrial Cobalt-60 Exposure Rate and Lead Shielding Design

An industrial radiographer works at distance $d_1 = 5.00\text{ m}$ from an unshielded $A = 200\text{ Ci}$ ($7.40\text{ TBq}$) $^{60}\text{Co}$ source ($\Gamma = 1.32\text{ R}\cdot\text{m}^2/\text{Ci}\cdot\text{h}$).

  1. Calculate the unshielded exposure rate $\dot{X}_1$ at $5.00\text{ m}$ in $\text{R/h}$ and the equivalent dose rate $\dot{H}_1$ in $\text{mSv/h}$ (using $1\text{ R} \approx 9.6\text{ mSv}$).
  2. If the worker moves to $d_2 = 1.00\text{ m}$, compute the dose rate $\dot{H}_2$.
  3. To work at $d = 2.00\text{ m}$ for $t = 8.0\text{ hours}$ without exceeding a daily administrative dose constraint of $0.10\text{ mSv}$ ($100\,\mu\text{Sv}$), determine the required thickness of lead shielding in centimeters ($\text{HVL}_{\text{Pb}} = 1.05\text{ cm}$).

Step 1: Unshielded Exposure Rate at $5.00\text{ m}$

$$\dot{X}_1 = \frac{\Gamma \cdot A}{d_1^2} = \frac{(1.32\text{ R}\cdot\text{m}^2/\text{Ci}\cdot\text{h})(200\text{ Ci})}{(5.00\text{ m})^2} = \frac{264}{25.0} = 10.56\text{ R/h}$$

Dose rate:

$$\dot{H}_1 = 10.56\text{ R/h} \times 9.6\text{ mSv/R} \approx 101.4\text{ mSv/h}$$

Step 2: Dose Rate at $1.00\text{ m}$

Using inverse square law:

$$\dot{H}_2 = \dot{H}_1 \left(\frac{d_1}{d_2}\right)^2 = 101.4\text{ mSv/h} \times \left(\frac{5.00}{1.00}\right)^2 = 101.4 \times 25 = 2,535\text{ mSv/h} \approx 2.54\text{ Sv/h}$$

Standing $1\text{ meter}$ away delivers a lethal dose in barely 2 hours!

Step 3: Shielding Design at $2.00\text{ m}$

Unshielded dose rate at $2.00\text{ m}$:

$$\dot{H}(2\text{ m}) = 101.4\text{ mSv/h} \times \left(\frac{5.00}{2.00}\right)^2 = 101.4 \times 6.25 \approx 633.75\text{ mSv/h}$$

Allowed dose rate for $8.0\text{ hours}$:

$$\dot{H}_{\text{allowed}} = \frac{0.10\text{ mSv}}{8.0\text{ h}} = 0.0125\text{ mSv/h}$$

Required attenuation factor $AF$:

$$AF = \frac{\dot{H}_{\text{unshielded}}}{\dot{H}_{\text{allowed}}} = \frac{633.75\text{ mSv/h}}{0.0125\text{ mSv/h}} = 50,700$$

Number of half-value layers ($n$):

$$2^n \ge 50,700 \implies n = \frac{\ln(50,700)}{\ln 2} = \frac{10.8337}{0.69315} \approx 15.63\text{ HVLs}$$

Shield thickness:

$$x = n \cdot \text{HVL} = 15.63 \times 1.05\text{ cm} \approx 16.41\text{ cm} = 164\text{ mm}$$

A lead shield of thickness $16.4\text{ cm}$ ($6.5\text{ inches}$) is required.

Easy Example 10.3: Internal Radionuclide Effective Half-Life and Committed Dose for I-131

A nuclear medicine laboratory technician accidentally inhales radioactive iodine-131 vapor ($^{131}\text{I}$, $T_p = 8.025\text{ days}$). In the thyroid gland, the biological clearance half-life of iodine is $T_b = 68.0\text{ days}$.

  1. Calculate the effective elimination constant $\lambda_{\text{eff}}$ in $\text{days}^{-1}$ and the effective half-life $T_{\text{eff}}$ in days.
  2. If the initial thyroid intake is $A_0 = 50.0\text{ kBq}$, calculate the remaining thyroid activity after $30.0\text{ days}$.
  3. Using the ICRP thyroid committed dose coefficient $e(50) = 4.3 \times 10^{-7}\text{ Sv/Bq}$, determine the committed thyroid equivalent dose in millisieverts ($\text{mSv}$).

Step 1: Effective Half-Life $T_{\text{eff}}$

Physical and biological decay constants:

$$\lambda_p = \frac{\ln 2}{8.025\text{ d}} \approx 0.086373\text{ d}^{-1}$$
$$\lambda_b = \frac{\ln 2}{68.0\text{ d}} \approx 0.010193\text{ d}^{-1}$$

Effective elimination constant:

$$\lambda_{\text{eff}} = \lambda_p + \lambda_b = 0.086373 + 0.010193 = 0.096566\text{ days}^{-1}$$

Effective half-life:

$$T_{\text{eff}} = \frac{\ln 2}{\lambda_{\text{eff}}} = \frac{0.693147}{0.096566\text{ d}^{-1}} \approx 7.178\text{ days}$$

Alternatively:

$$T_{\text{eff}} = \frac{T_p \cdot T_b}{T_p + T_b} = \frac{8.025 \times 68.0}{8.025 + 68.0} = \frac{545.70}{76.025} \approx 7.178\text{ days}$$

Step 2: Remaining Activity After $30.0\text{ Days}$

$$A(30) = A_0 e^{-\lambda_{\text{eff}} t} = 50.0\text{ kBq} \times \exp(-0.096566 \times 30.0) = 50.0 \times e^{-2.8970}$$
$$A(30) = 50.0 \times 0.055189 \approx 2.76\text{ kBq}$$

Step 3: Committed Equivalent Dose

$$H_{\text{thyroid}} = A_{\text{intake}} \cdot e(50) = (50,000\text{ Bq})(4.3 \times 10^{-7}\text{ Sv/Bq}) = 0.0215\text{ Sv} = 21.5\text{ mSv}$$

The technician receives a committed thyroid dose of $21.5\text{ mSv}$.

Intermediate Example 10.4: Linear-Quadratic Model Dose Fractionation Sparing in Radiation Oncology

In clinical radiotherapy, a tumor has an $\alpha/\beta$ ratio of $10.0\text{ Gy}$ ($\alpha = 0.30\text{ Gy}^{-1}, \beta = 0.030\text{ Gy}^{-2}$). Surrounding late-responding healthy normal tissue has $\alpha/\beta = 2.50\text{ Gy}$ ($\alpha_{\text{norm}} = 0.10\text{ Gy}^{-1}, \beta_{\text{norm}} = 0.040\text{ Gy}^{-2}$). Compare two treatment regimes delivering a total physical dose $D_{\text{total}} = 60.0\text{ Gy}$:

  • Regime A: Single massive fraction of $60.0\text{ Gy}$.
  • Regime B: 30 daily fractions of $d = 2.00\text{ Gy}$ ($30 \times 2.0 = 60.0\text{ Gy}$).
  1. Calculate the Biologically Effective Dose ($\text{BED} = D [1 + d/(\alpha/\beta)]$) for the tumor and normal tissue under both regimes.
  2. Explain the therapeutic gain achieved by dose fractionation.

Step 1: Biologically Effective Dose (BED) Calculations

Formula: $\text{BED} = D_{\text{total}} \left(1 + \frac{d}{\alpha/\beta}\right)$.

1. Regime A: Single Fraction ($d = 60.0\text{ Gy}$):

  • Tumor ($\alpha/\beta = 10\text{ Gy}$):
$$\text{BED}_{\text{tumor}} = 60.0 \left(1 + \frac{60.0}{10.0}\right) = 60.0(1 + 6.0) = 420\text{ Gy}_{10}$$
  • Normal Tissue ($\alpha/\beta = 2.5\text{ Gy}$):
$$\text{BED}_{\text{normal}} = 60.0 \left(1 + \frac{60.0}{2.5}\right) = 60.0(1 + 24.0) = 1,500\text{ Gy}_{2.5}$$

The biological damage to healthy tissue ($1,500\text{ Gy}$) is catastrophic, causing lethal necrosis!

2. Regime B: 30 Fractions of $2.00\text{ Gy}$ ($d = 2.00\text{ Gy}$):

  • Tumor:
$$\text{BED}_{\text{tumor}} = 60.0 \left(1 + \frac{2.00}{10.0}\right) = 60.0(1 + 0.20) = 72.0\text{ Gy}_{10}$$
  • Normal Tissue:
$$\text{BED}_{\text{normal}} = 60.0 \left(1 + \frac{2.00}{2.5}\right) = 60.0(1 + 0.80) = 108.0\text{ Gy}_{2.5}$$

Step 2: Therapeutic Gain Explanation

In Regime B, fractionating the dose into $2\text{ Gy}$ increments exploits the difference in repair capacities: Because normal tissue has a broad curve shoulder ($\beta = 0.040$), dividing the dose into small increments allows sublethal damage repair between daily fractions ($24\text{ hours}$ apart). The biological damage to normal tissue drops from $1,500\text{ Gy}$ to $108\text{ Gy}$β€”a fourteen-fold sparing of healthy tissue while sterilizing the tumor cells!

Intermediate Example 10.5: Deterministic Acute Radiation Syndrome LD50 Probit Curve

In radiobiological toxicology, the mortality of mammals exposed to acute whole-body gamma radiation follows a sigmoid probit curve described by the cumulative normal distribution:

$$P(\text{Death}) = \frac{1}{\sqrt{2\pi}} \int_{-\infty}^{Y - 5} e^{-u^2/2} du$$

where $Y = a + b \log_{10}(D)$. For humans without specialized intensive medical intervention:

  • $\text{LD}_{50/60}$ (lethal dose to $50\%$ of population within 60 days) is $D_{50} = 3.50\text{ Gy}$.
  • $\text{LD}_{10/60}$ is $D_{10} = 2.20\text{ Gy}$.
  1. Compute the probit slope parameter $b$ and intercept $a$.
  2. Calculate the estimated $\text{LD}_{90/60}$ dose in Grays.
  3. Determine the predicted mortality percentage for an accidental acute whole-body absorbed dose of $D = 4.50\text{ Gy}$.

Step 1: Probit Parameters $a$ and $b$

In standard probit tables:

  • $P = 50\% \implies \text{Probit } Y = 5.00$
  • $P = 10\% \implies \text{Probit } Y = 3.72$ (from $z = -1.282 \implies 5 - 1.282 = 3.718$)
  • $P = 90\% \implies \text{Probit } Y = 6.28$ (from $z = +1.282 \implies 5 + 1.282 = 6.282$)

Set up linear equations:

$$\log_{10}(D_{50}) = \log_{10}(3.50) \approx 0.54407 \implies 5.00 = a + b(0.54407)$$
$$\log_{10}(D_{10}) = \log_{10}(2.20) \approx 0.34242 \implies 3.718 = a + b(0.34242)$$

Subtracting:

$$5.00 - 3.718 = 1.282 = b(0.54407 - 0.34242) = b(0.20165)$$
$$b = \frac{1.282}{0.20165} \approx 6.3575$$
$$a = 5.00 - (6.3575 \times 0.54407) = 5.00 - 3.4589 = 1.5411$$

Step 2: Calculate $\text{LD}_{90/60}$

At $90\%$ mortality, $Y = 6.282$:

$$6.282 = 1.5411 + 6.3575 \log_{10}(D_{90})$$
$$\log_{10}(D_{90}) = \frac{6.282 - 1.5411}{6.3575} = \frac{4.7409}{6.3575} \approx 0.74571$$
$$D_{90} = 10^{0.74571} \approx 5.568\text{ Gy}$$

The $\text{LD}_{90/60}$ dose is $5.57\text{ Gy}$.

Step 3: Mortality at $D = 4.50\text{ Gy}$

$$\log_{10}(4.50) \approx 0.65321$$
$$Y = 1.5411 + 6.3575(0.65321) = 1.5411 + 4.1528 = 5.6939$$

Standard normal deviate:

$$z = Y - 5.00 = 5.6939 - 5.00 = +0.6939$$

From standard normal CDF tables, $\Phi(0.694) \approx 0.7562$. Predicted mortality: $75.6\%$ of exposed individuals will succumb to hematopoietic bone marrow syndrome within 60 days unless treated with colony-stimulating factors (G-CSF) or bone marrow transplants.

Easy Example 10.6: Linear No-Threshold Lifetime Cancer Risk Assessment for Occupational Cohort

A nuclear decommissioning team of 250 radiological workers operates in a contaminated reprocessing cell. Each worker receives an average annual effective dose of $14.0\text{ mSv}$ over a 5-year project duration. Using the ICRP nominal stochastic cancer risk coefficient of $5.5 \times 10^{-2}\text{ Sv}^{-1}$ ($5.5\%\text{ per Sievert}$):

  1. Calculate the cumulative 5-year effective dose received per worker in Sieverts ($\text{Sv}$).
  2. Compute the collective effective dose to the entire workforce in person-Sieverts ($\text{person-Sv}$).
  3. Estimate the statistical number of excess fatal stochastic radiation-induced cancers predicted by the LNT model over the lifetime of the cohort.

Step 1: Cumulative Dose Per Worker

$$\text{Dose per worker} = 14.0\text{ mSv/year} \times 5\text{ years} = 70.0\text{ mSv} = 0.0700\text{ Sv}$$

Step 2: Collective Effective Dose ($S$)

$$S = N \cdot E = 250\text{ workers} \times 0.0700\text{ Sv} = 17.50\text{ person-Sv}$$

The total collective dose is $17.5\text{ person-Sieverts}$.

Step 3: Predicted Excess Fatal Cancers

Under the LNT model:

$$\text{Expected Fatal Cancers} = S \times \text{Risk Coefficient}$$
$$\text{Expected Cancers} = 17.50\text{ person-Sv} \times 0.055\text{ Sv}^{-1} \approx 0.9625$$

The LNT model predicts approximately $0.96$ excess fatal cancers ($\sim 1$ case) across the entire 250-person cohort over their remaining lifetimes.

Intermediate Example 10.7: Diagnostic Fluoroscopy Patient Skin Dose and Air Kerma-Area Product (KAP)

During an interventional cardiac fluoroscopy procedure, the X-ray tube operates at an air kerma rate at the patient's entrance skin surface of $\dot{K}_{\text{air}} = 45.0\text{ mGy/min}$. The fluoroscopic beam irradiation field size at the skin is $12.0\text{ cm} \times 12.0\text{ cm}$. The backscatter factor from underlying patient tissue is $B_{\text{tissue}} = 1.35$. The mass-energy absorption coefficient ratio of tissue to air is $(\mu_{\text{en}}/\rho)_{\text{air}}^{\text{tissue}} = 1.06$. Total beam-on fluoroscopy time is $t = 35.0\text{ minutes}$.

  1. Calculate the total free-in-air entrance kerma in Grays ($\text{Gy}$).
  2. Compute the cumulative peak Entrance Skin Dose (ESD) to the patient in Grays, and determine whether the threshold for deterministic skin erythema ($2.0\text{ Gy}$) is exceeded.
  3. Calculate the Kerma-Area Product (KAP or DAP) in $\text{Gy}\cdot\text{cm}^2$.

Step 1: Free-in-Air Entrance Kerma

$$K_{\text{air}} = \dot{K}_{\text{air}} \times t = 45.0\text{ mGy/min} \times 35.0\text{ min} = 1,575\text{ mGy} = 1.575\text{ Gy}$$

Step 2: Entrance Skin Dose (ESD)

The Entrance Skin Dose accounts for tissue absorption and backscatter radiation:

$$\text{ESD} = K_{\text{air}} \cdot B_{\text{tissue}} \cdot \left(\frac{\mu_{\text{en}}}{\rho}\right)_{\text{air}}^{\text{tissue}}$$
$$\text{ESD} = 1.575\text{ Gy} \times 1.35 \times 1.06 = 1.575 \times 1.431 \approx 2.2539\text{ Gy}$$

The skin dose is $2.25\text{ Gy}$. Because $\text{ESD} = 2.25\text{ Gy} > 2.0\text{ Gy}$, the clinical threshold for deterministic transient radiation skin erythema is exceeded. Clinical follow-up at $2 - 4\text{ weeks}$ is mandated to monitor for skin burns.

Step 3: Kerma-Area Product (KAP)

Beam field area:

$$A = 12.0\text{ cm} \times 12.0\text{ cm} = 144.0\text{ cm}^2$$
$$\text{KAP} = K_{\text{air}} \cdot A = 1.575\text{ Gy} \times 144.0\text{ cm}^2 = 226.8\text{ Gy}\cdot\text{cm}^2$$

The KAP is $226.8\text{ Gy}\cdot\text{cm}^2$ (or $22.68\text{ Gy}\cdot\text{m}^2$).

Easy Example 10.8: Air Kerma Rate Constant and Shielding Calculation for Technetium-99m Syringe

A nuclear medicine technologist prepares a patient injection syringe containing $A = 30.0\text{ mCi}$ ($1,110\text{ MBq}$) of $^{99m}\text{Tc}$ ($E_\gamma = 140.5\text{ keV}$). The air kerma rate constant is $\Gamma_\delta = 17.0\,\mu\text{Gy}\cdot\text{m}^2 / (\text{GBq}\cdot\text{h}) = 0.076\text{ R}\cdot\text{m}^2 / (\text{Ci}\cdot\text{h})$.

  1. Calculate the unshielded dose rate at distance $d = 1.00\text{ meter}$ and at distance $d = 10.0\text{ cm}$ in $\mu\text{Sv/h}$ ($w_R = 1$).
  2. The technologist holds the syringe inside a tungsten syringe shield of thickness $x = 2.0\text{ mm}$ ($\text{HVL}_{\text{tungsten}} = 0.40\text{ mm}$ for $140\text{ keV}$). Determine the transmission factor and the attenuated dose rate at $10.0\text{ cm}$.
  3. Calculate the hand dose received during a $30\text{-second}$ injection.

Step 1: Unshielded Dose Rates

At $d = 1.00\text{ meter}$:

$$\dot{H}(1\text{ m}) = \frac{\Gamma \cdot A}{d^2} = \frac{(17.0\,\mu\text{Sv}\cdot\text{m}^2/\text{GBq}\cdot\text{h})(1.110\text{ GBq})}{(1.00\text{ m})^2} = 18.87\,\mu\text{Sv/h}$$

At $d = 10.0\text{ cm} = 0.100\text{ m}$:

$$\dot{H}(0.10\text{ m}) = 18.87\,\mu\text{Sv/h} \times \left(\frac{1.00}{0.100}\right)^2 = 18.87 \times 100 = 1,887\,\mu\text{Sv/h} \approx 1.89\text{ mSv/h}$$

Step 2: Tungsten Shield Attenuation

Shield thickness: $x = 2.0\text{ mm}$. Number of half-value layers:

$$n = \frac{x}{\text{HVL}} = \frac{2.0\text{ mm}}{0.40\text{ mm}} = 5.0\text{ HVLs}$$

Transmission factor:

$$T = \left(\frac{1}{2}\right)^n = \left(\frac{1}{2}\right)^5 = \frac{1}{32} \approx 0.03125 \quad (3.125\%)$$

Attenuated dose rate at $10\text{ cm}$:

$$\dot{H}_{\text{shielded}} = 1,887\,\mu\text{Sv/h} \times 0.03125 \approx 59.0\,\mu\text{Sv/h}$$

Step 3: Injection Dose

Injection duration: $t = 30\text{ seconds} = 30 / 3600\text{ h} = 0.008333\text{ h}$.

$$\text{Hand Dose} = (59.0\,\mu\text{Sv/h}) \times (0.008333\text{ h}) \approx 0.492\,\mu\text{Sv}$$

The tungsten shield reduces the hand dose to barely $0.49\,\mu\text{Sv}$ (compared to $15.7\,\mu\text{Sv}$ unshielded), ensuring total ALARA protection across hundreds of injections!

Advanced Example 10.9: ICRP Compartmental Biokinetic Model for Inhaled Insoluble Plutonium-239

A radiological worker accidentally inhales insoluble high-fired plutonium dioxide ($^{239}\text{Pu}\text{O}_2$, Type S aerosol, $T_p = 24,110\text{ years}$, alpha energy $E_\alpha = 5.15\text{ MeV}$). Under the ICRP 66 Human Respiratory Tract Model, $10.0\%$ of the initial intake deposits in the alveolar-interstitial ($AI$) region of the lungs. For Type S particulates, the biological clearance from the $AI$ region follows two compartments:

  • $90\%$ clears with biological half-time $T_{b,1} = 7,000\text{ days}$
  • $10\%$ is retained permanently ($T_{b,2} = \infty$)

The mass of the human lung is $m_{\text{lung}} = 1.00\text{ kg}$. For an acute alveolar intake of $A_0 = 1,000\text{ Bq}$ of $^{239}\text{Pu}$:

  1. Calculate the initial alpha energy deposition rate in the lung in Joules per day.
  2. Determine the total alpha energy imparted to the lungs over the first year ($365\text{ days}$) in Joules.
  3. Compute the cumulative lung absorbed dose in Grays ($Gy$) and the equivalent dose in Sieverts ($Sv$, with $w_R = 20$) over the first year.

Step 1: Initial Alpha Energy Deposition Rate

Energy per alpha decay:

$$E_\alpha = 5.15\text{ MeV} = 5.15 \times 1.60218 \times 10^{-13}\text{ J} \approx 8.2512 \times 10^{-13}\text{ J per decay}$$

Activity: $A_0 = 1,000\text{ Bq} = 1,000\text{ decays/second}$. Daily alpha energy rate:

$$\dot{E} = (1000\text{ s}^{-1}) \times (8.2512 \times 10^{-13}\text{ J}) \times (86,400\text{ s/day}) \approx 7.129 \times 10^{-5}\text{ J/day}$$

Step 2: Total Energy Imparted Over Year 1

Because $T_{b,1} = 7,000\text{ days} \gg 365\text{ days}$ (and $T_p = 24,110\text{ years}$), clearance over the first year is negligible:

$$\lambda_b = \frac{\ln 2}{7000\text{ d}} \approx 9.902 \times 10^{-5}\text{ d}^{-1} \implies e^{-\lambda_b (365)} \approx 0.9645$$

Average activity over the year:

$$\bar{A} \approx A_0 \left(1 - \frac{1}{2} \lambda_b t\right) = 1000 \times [1 - 0.5(0.0361)] \approx 982\text{ Bq}$$

Total alpha disintegrations in 365 days:

$$N_{\text{decays}} \approx 982\text{ s}^{-1} \times (365 \times 86400\text{ s}) \approx 3.10 \times 10^{10}\text{ decays}$$

Total imparted energy:

$$E_{\text{total}} = (3.10 \times 10^{10}) \times (8.2512 \times 10^{-13}\text{ J}) \approx 0.02558\text{ Joules}$$

Step 3: Absorbed and Equivalent Lung Dose

1. Absorbed Dose ($D$):

$$D = \frac{E_{\text{total}}}{m_{\text{lung}}} = \frac{0.02558\text{ J}}{1.00\text{ kg}} \approx 0.02558\text{ Gy} = 25.6\text{ mGy}$$

2. Equivalent Dose ($H$):

With alpha radiation weighting factor $w_R = 20$:

$$H_{\text{lung}} = w_R \cdot D = 20 \times 25.58\text{ mGy} \approx 511.6\text{ mSv} \approx 0.512\text{ Sv}$$

A mere $1,000\text{ Bq}$ (barely $0.44\text{ micrograms}$) of insoluble $^{239}\text{Pu}$ delivers over half a Sievert ($512\text{ mSv}$) of equivalent dose to the lung in the first year alone, illustrating the extreme radiological hazard of alpha-emitting actinide aerosols!

Solved Honors Problems & Derivations

Step-by-step rigorous solutions with full physical, thermodynamic, and nuclear kinematic validation.